Hemodialysis is a life-sustaining treatment for people with severe kidney disease. It involves passing the patient’s blood through an artificial kidney, which filters out waste products and excess fluids.
However, hemodialysis requires the creation of a vascular access, usually by surgically creating a fistula or graft in the patient’s arm. Unfortunately, these access points are prone to complications such as infection and clotting, which can damage the blood vessels and limit their longevity.
Artificial blood vessels offer a promising solution to this problem, providing a reliable and durable conduit for hemodialysis treatments.
What are artificial blood vessels?
Artificial blood vessels are man-made conduits that mimic the properties of natural blood vessels in the body.
They are typically made of biocompatible materials such as polytetrafluoroethylene (PTFE) or expanded polytetrafluoroethylene (ePTFE), which have been shown to promote good blood flow and minimize complications such as clotting and infection. The artificial blood vessel is surgically implanted into the patient, providing a conduit for blood flow that can be easily accessed during hemodialysis treatments.
How do artificial blood vessels improve hemodialysis?
The use of artificial blood vessels can significantly improve the success of hemodialysis treatments. Here are some of the key benefits:.
Reduced complications
Traditional vascular access points such as fistulas and grafts can be prone to complications such as infection, clotting, and stenosis (narrowing of the blood vessels).
These complications not only limit the lifespan of the access point, but also increase the risk of serious medical complications such as sepsis. Artificial blood vessels, on the other hand, are less prone to these complications and can offer a more reliable conduit for long-term hemodialysis.
Greater flexibility
Artificial blood vessels can be created in a variety of shapes and sizes to suit the patient’s specific needs.
This can be particularly beneficial for patients who have complex vascular anatomy or have exhausted their options for traditional vascular access points. Artificial blood vessels can also be placed in different locations in the body, such as the leg or thigh, which can provide greater comfort and convenience for the patient during hemodialysis treatments.
Improved blood flow
Artificial blood vessels have been shown to provide better blood flow during hemodialysis treatments. This is because they are typically smoother and less prone to stenosis than traditional vascular access points.
In addition, some artificial blood vessels are designed to mimic the outward appearance of natural blood vessels, which can encourage the growth of new blood vessels around the implant site (known as neovascularization) and improve blood flow even further.
Types of artificial blood vessels
There are several different types of artificial blood vessels that are currently in use or under development. Here are a few examples:.
PTFE grafts
PTFE grafts are a type of artificial blood vessel that are commonly used in hemodialysis. They are made of a polymer called polytetrafluoroethylene (PTFE) and have a porous inner surface that promotes good blood flow.
PTFE grafts are typically more durable than fistulas, but they can still be prone to complications such as infection and clotting.
ePTFE grafts
ePTFE grafts are a newer type of artificial blood vessel that are made of an expanded form of PTFE.
They have a microporous structure that encourages the growth of new blood vessels around the implant site, which can improve blood flow and reduce complications. ePTFE grafts have been shown to be more durable than traditional PTFE grafts and are becoming increasingly popular for hemodialysis access.
Bioengineered blood vessels
Bioengineered blood vessels are a cutting-edge technology that involves creating artificial blood vessels using living cells. These cells are grown in the lab and then seeded onto a scaffold made of biocompatible materials such as collagen or silk.
Over time, the cells grow and form a functioning blood vessel that can be implanted into the patient. Bioengineered blood vessels have shown great promise in animal studies and are currently undergoing clinical trials for use in humans.
Conclusion
Artificial blood vessels are an exciting development in the world of hemodialysis.
They offer a reliable and durable conduit for blood flow during hemodialysis treatments, and have the potential to significantly reduce complications and improve patient outcomes. As technology continues to advance, we can expect to see even more innovative approaches to artificial blood vessel development that will help to improve the lives of kidney disease patients around the world.